TR200200506T2 - Küre şeklinde telitromisin kümeleri, bunların üretimi için yöntem - Google Patents

Küre şeklinde telitromisin kümeleri, bunların üretimi için yöntem

Info

Publication number
TR200200506T2
TR200200506T2 TR2002/00506T TR200200506T TR200200506T2 TR 200200506 T2 TR200200506 T2 TR 200200506T2 TR 2002/00506 T TR2002/00506 T TR 2002/00506T TR 200200506 T TR200200506 T TR 200200506T TR 200200506 T2 TR200200506 T2 TR 200200506T2
Authority
TR
Turkey
Prior art keywords
production
clusters
telithromycin
spherical
spherical telithromycin
Prior art date
Application number
TR2002/00506T
Other languages
English (en)
Turkish (tr)
Inventor
Godard Jean-Yves
Rognon - Ravaux Val�Rie
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9549351&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200200506(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of TR200200506T2 publication Critical patent/TR200200506T2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TR2002/00506T 1999-08-26 2000-08-28 Küre şeklinde telitromisin kümeleri, bunların üretimi için yöntem TR200200506T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9910810A FR2797875B1 (fr) 1999-08-26 1999-08-26 Agglomerats spheriques de telithromycine, leur procede de preparation et leur application dans la preparation de formes pharmaceutiques

Publications (1)

Publication Number Publication Date
TR200200506T2 true TR200200506T2 (tr) 2002-08-21

Family

ID=9549351

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/00506T TR200200506T2 (tr) 1999-08-26 2000-08-28 Küre şeklinde telitromisin kümeleri, bunların üretimi için yöntem

Country Status (34)

Country Link
US (1) US6825218B1 (https=)
EP (1) EP1212336B1 (https=)
JP (1) JP4871467B2 (https=)
KR (1) KR100718222B1 (https=)
CN (1) CN1183151C (https=)
AR (1) AR025398A1 (https=)
AT (1) ATE255590T1 (https=)
AU (1) AU774385B2 (https=)
BR (1) BR0013569B1 (https=)
CA (1) CA2382497C (https=)
CO (1) CO5190666A1 (https=)
CZ (1) CZ2002594A3 (https=)
DE (1) DE60006976T2 (https=)
DK (1) DK1212336T3 (https=)
EA (1) EA005080B1 (https=)
ES (1) ES2209970T3 (https=)
FR (1) FR2797875B1 (https=)
HK (1) HK1049167B (https=)
HR (1) HRP20020167B1 (https=)
HU (1) HU229075B1 (https=)
IL (2) IL148128A0 (https=)
ME (2) MEP20108A (https=)
MX (1) MXPA02001988A (https=)
NO (1) NO322622B1 (https=)
PL (1) PL204100B1 (https=)
PT (1) PT1212336E (https=)
RS (1) RS50433B (https=)
SI (1) SI1212336T1 (https=)
SK (1) SK287588B6 (https=)
TR (1) TR200200506T2 (https=)
TW (1) TWI272949B (https=)
UA (1) UA73523C2 (https=)
WO (1) WO2001014393A2 (https=)
ZA (1) ZA200201599B (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9902202D0 (sv) * 1999-06-10 1999-06-10 Astra Ab Production of aggregates
FR2821747B1 (fr) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques Suspension de telithromycine a gout masque
JP2005533121A (ja) * 2002-07-19 2005-11-04 アベンティス・ファーマ・ソシエテ・アノニム テリスロマイシンの味覚マスキングされた経口組成物
WO2004009059A1 (en) * 2002-07-19 2004-01-29 Aventis Pharma S.A. Taste masked oral composition of telithromycin
US20040013737A1 (en) * 2002-07-19 2004-01-22 Philippe Becourt Taste masked oral composition of telithromycin
PL224720B1 (pl) * 2003-02-21 2017-01-31 Univ Bath Sposób wytwarzania cząstek krystalicznych, cząstki krystaliczne oraz kompozycja farmaceutyczna je zawierająca
WO2005007143A2 (en) * 2003-07-14 2005-01-27 The Board Of Trustees Of The University Of Illinois Use of makrolides and ketolides for the treatment of tuberculosis
WO2007039914A2 (en) * 2005-10-06 2007-04-12 Alembic Limited Novel polymorphs of telithromycin
US20090075917A1 (en) * 2007-09-19 2009-03-19 Protia, Llc Deuterium-enriched telithromycin
KR101324862B1 (ko) * 2011-07-12 2013-11-01 (주)에이에스텍 클로피도그렐 황산수소염의 구형 입자, 이를 포함하는 약학적 조성물 및 이의 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0130160B1 (en) * 1983-06-22 1988-01-07 The Ohio State University Research Foundation Small particle formation
JPH02227130A (ja) * 1989-02-28 1990-09-10 Taisho Pharmaceut Co Ltd 球形微小凍結粒子の製造法
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
CO5190666A1 (es) 2002-08-29
CA2382497A1 (fr) 2001-03-01
CA2382497C (fr) 2011-06-28
WO2001014393A2 (fr) 2001-03-01
PL204100B1 (pl) 2009-12-31
HK1049167B (zh) 2005-08-19
JP2003507484A (ja) 2003-02-25
DK1212336T3 (da) 2004-03-15
MEP20108A (en) 2010-06-10
NO20020926D0 (no) 2002-02-26
SK2532002A3 (en) 2002-09-10
ZA200201599B (en) 2003-04-30
HRP20020167B1 (en) 2006-06-30
YU13202A (sh) 2004-09-03
FR2797875A1 (fr) 2001-03-02
NO322622B1 (no) 2006-11-06
SI1212336T1 (en) 2004-04-30
BR0013569A (pt) 2002-05-14
ME00112B (me) 2010-10-10
FR2797875B1 (fr) 2001-10-19
EP1212336B1 (fr) 2003-12-03
IL148128A (en) 2006-10-31
EA005080B1 (ru) 2004-10-28
PL353137A1 (en) 2003-10-20
AR025398A1 (es) 2002-11-27
AU7018100A (en) 2001-03-19
US6825218B1 (en) 2004-11-30
TWI272949B (en) 2007-02-11
ATE255590T1 (de) 2003-12-15
KR20020033771A (ko) 2002-05-07
HK1049167A1 (en) 2003-05-02
UA73523C2 (uk) 2005-08-15
HUP0202842A3 (en) 2003-03-28
EP1212336A2 (fr) 2002-06-12
HRP20020167A2 (en) 2003-06-30
AU774385B2 (en) 2004-06-24
CN1371386A (zh) 2002-09-25
CN1183151C (zh) 2005-01-05
CZ2002594A3 (cs) 2002-09-11
NO20020926L (no) 2002-02-26
PT1212336E (pt) 2004-04-30
ES2209970T3 (es) 2004-07-01
HUP0202842A2 (hu) 2003-01-28
EA200200294A1 (ru) 2002-08-29
IL148128A0 (en) 2002-09-12
DE60006976D1 (de) 2004-01-15
HU229075B1 (hu) 2013-07-29
DE60006976T2 (de) 2004-10-21
BR0013569B1 (pt) 2014-02-25
SK287588B6 (sk) 2011-03-04
WO2001014393A3 (fr) 2001-06-21
MXPA02001988A (es) 2002-08-20
RS50433B (sr) 2009-12-31
JP4871467B2 (ja) 2012-02-08
KR100718222B1 (ko) 2007-05-15

Similar Documents

Publication Publication Date Title
TR200200506T2 (tr) Küre şeklinde telitromisin kümeleri, bunların üretimi için yöntem
DE60100542D1 (de) Herstellungsverfahren von kolloidale systeme enthaltenden mikrokugeln
NO20000841L (no) N-Aroylfenylalanin-derivater
TR200200551A2 (tr) Ana kiriş bağlantısı.
WO2001034835A3 (en) Method for the production of biopolymers with modified properties
DK1483390T3 (da) Transgene planter, der syntetiserer stivelse med höjt amyloseindhold
DK1175398T3 (da) Indolinderivater som progesteronantagonister
NZ601689A (en) Crystalline forms for 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt, pharmaceutical preparations containing the same and method for the production of said forms
AT504347B8 (de) Verfahren zur herstellung von glucosederivaten
WO2006050365A3 (en) Methods for production of synthetic hydroxyapatite nanorods
AU3436601A (en) Decoding of array sensors with microspheres
YU4402A (sh) Novi derivati vitamina d sa cikličnim podstrukturama u bočnim lancima, postupak i međuproizvodi za njihovu proizvodnju i primena za proizvodnju lekova
NO20010516L (no) Krystallmodifisering av liponsyre
WO2005094316A3 (en) Low optical overlap mode (loom) waveguiding system and method of making same
ID27660A (id) Modifikasi kristal dari zat farmasi
Masuda et al. Effect of temperature on the Ca2+ transport ATPase of sarcoplasmic reticulum
NO20004919L (no) Fremgangsmåte for fremstilling av 5-hydroksybenzo[b]tiofen-3- karboksylsyrederivater
Salvo et al. Modulation of aortic protein phosphatase activity by polylysine
EP0260093A3 (en) Methods for production of cellulose i involving in vitro synthesis
PT1578342E (pt) Processo para a preparação de uma composição de libertação programada com venlafaxina e produto resultante
MX9300481A (es) Variedad mutante de maiz y metodo para su produccion.
CN106006699B (zh) 一种制备高白超细硫酸钙粉体的方法
WO2004092188A3 (en) Analogs of lysophosphatidic acid and methods of making and using thereof
ES8609470A1 (es) Procedimiento para la inmovilizacion de celulas de bacillus subtilis
Hadley FARNESYL PYROPHOSPHATE ANALOGS: SUBSTRATES AND INHIBITORS OF SQUALENE SYNTHETASE.